Region Desk

China IP News

Region-focused IP developments curated by the IIPLA newsroom, including policy shifts, litigation, brand disputes, patent activity, and enforcement updates.

China Reports Robust Growth in Patent Transfers and Licensing in Early 2026
Patents

China Reports Robust Growth in Patent Transfers and Licensing in Early 2026

In the first three quarters of 2026, China recorded a 7.1% year-on-year rise in patent transfer and licensing filings, reaching nearly half a million transactions nationwide. The growth was highlighted at the 15th China International Patent Fair in Wuxi, where officials also reported sustained expansion in intellectua…

Friday, November 6, 2026
Shanghai Court Affirms Malicious Litigation Finding, Awards Bosch Legal Costs
Litigation

Shanghai Court Affirms Malicious Litigation Finding, Awards Bosch Legal Costs

A Shanghai court has confirmed a prior finding that a lawsuit filed against Bosch was malicious in nature. The court’s decision includes an order for the opposing party to cover Bosch’s litigation costs, reinforcing protections against abusive legal actions in China’s judicial system.

Thursday, November 5, 2026
First Solar Shifts Patent Enforcement Strategy Amid New US Polysilicon Tariffs
Litigation

First Solar Shifts Patent Enforcement Strategy Amid New US Polysilicon Tariffs

First Solar, the leading US solar panel manufacturer, has recalibrated its patent enforcement approach by voluntarily withdrawing its Section 337 complaint at the US International Trade Commission. This strategic pivot follows the Trump Administration’s imposition of a 15% tariff on polysilicon imports under Section 2…

Thursday, September 17, 2026
Godavari Biorefineries Secures Chinese Patent for Antiviral Compounds Targeting V-ATPase
Patents

Godavari Biorefineries Secures Chinese Patent for Antiviral Compounds Targeting V-ATPase

Godavari Biorefineries has been granted a Chinese patent for chemical compounds that inhibit V-ATPase activity to treat viral infections, marking a significant advancement in its biopharmaceutical R&D pipeline. This patent complements existing Japanese and European patents but is unlikely to impact near-term earnings,…

Wednesday, September 16, 2026
Newsletters & Digests

Get China IP News

Subscribe to region-aware daily digests and weekly editorial roundups focused on China.

Choose your regions
Choose your categories
By subscribing, you agree to receive IIPLA newsroom emails. You can update preferences or unsubscribe anytime.